Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |